Mativ Holdings, Inc. 2025 Annual Report (10-K) Summary
Business Context and Reporting Period
This filing is the Annual Report on Form 10-K for Mativ Holdings, Inc. (NYSE: MATV) for the fiscal year ended December 31, 2025. Mativ is a global leader in specialty materials, operating through two primary segments: Filtration & Advanced Materials (FAM) and Sustainable & Adhesive Solutions (SAS). The company manufactures engineered media, films, tapes, and specialty papers for end-markets including healthcare, filtration, construction, and packaging. Notably, the Engineered Papers business was divested in late 2023 and is reported as a discontinued operation.
Key Financial Metrics
| Metric | 2025 | 2024 |
|---|---|---|
| Net Sales | $1,987.0 million | $1,981.1 million |
| Gross Profit | $362.9 million (18.3% margin) | $364.1 million (18.4% margin) |
| Operating Profit (Loss) | $(384.4) million | $6.3 million |
| Net Loss | $(337.4) million | $(48.7) million |
| Diluted EPS | $(6.19) | $(0.90) |
| Operating Cash Flow | $133.8 million | $94.8 million |
| Total Debt | $1,018.2 million | $1,089.3 million |
| Cash & Equivalents | $84.2 million | $94.3 million |
| Net Leverage Ratio | 4.2x | N/A |
Material Changes vs. Prior Period
- Goodwill Impairment: The primary driver of the 2025 net loss was a non-cash goodwill impairment charge of $411.9 million recorded in the first quarter. This charge fully impaired the goodwill associated with the Filtration & Advanced Materials (FAM) segment due to a sustained decline in share price and increased discount rates reflecting market risk.
- Revenue Stability: Net sales increased slightly by 0.3% ($5.9 million) year-over-year. The FAM segment saw flat sales (+0.1%), while the SAS segment grew 0.4% driven by volume/mix and pricing, partially offset by exited facilities.
- Segment Performance: Excluding the goodwill impairment, the FAM segment generated an operating profit of $52.1 million (down $17.9 million from 2024 due to higher costs). The SAS segment operating profit increased to $85.6 million (up $40.2 million) driven by favorable pricing and lower manufacturing costs.
- Restructuring: Restructuring and other impairment expenses totaled $19.9 million in 2025, a decrease from $38.1 million in 2024, as the company accelerated cost-saving initiatives ("the Plan") to deliver nearly $20.0 million in savings in 2025.
- Debt Reduction: Total debt decreased by $71.1 million year-over-year, with net leverage at 4.2x, well below the 5.50x covenant maximum.
Guidance, Outlook, and Risks
- Outlook: Management expects long-term growth in the FAM segment to exceed broad economic growth in the U.S. and Europe. The SAS segment is expected to grow in line with broad economic growth. No specific numerical guidance for 2026 revenue or earnings was provided in this text.
- Cost Initiatives: The company projects an additional $15.0 million to $20.0 million in cost reductions by the end of 2026 from its organizational realignment plan.
- Key Risks:
- Trade Policy: Significant uncertainty regarding U.S. tariffs and retaliatory measures implemented in 2025, which have increased costs of goods sold.
- Commodity Prices: Volatility in resin and wood pulp prices impacts margins; the company has limited ability to pass these costs through immediately.
- Goodwill: Continued risk of further impairment if market capitalization declines or cash flow forecasts deteriorate.
- Geopolitics: Exposure to energy price volatility in Europe and supply chain disruptions due to conflicts in the Middle East and Russia/Ukraine.
- Management Changes: Greg Weitzel departed as CFO effective December 31, 2025. Scott Minder was appointed CFO effective January 1, 2026.
Investor Verification Checklist
- Goodwill Valuation: Verify the assumptions used in the Q1 2025 impairment test, specifically the 14% discount rate applied to the FAM segment and the sensitivity of fair value to share price fluctuations.
- Tariff Impact: Assess the specific financial impact of 2025 U.S. tariff implementations on the cost of goods sold and the company's ability to pass these costs to customers.
- Debt Covenants: Confirm compliance with the 5.50x net debt-to-EBITDA covenant and the 2.50x interest coverage ratio, noting the step-down/step-up schedules effective in 2026.
- Segment Margins: Analyze the divergence between the FAM segment (impairment-driven loss) and SAS segment (profit growth) to understand underlying operational health excluding non-cash charges.
- Working Capital: Review the $8.4 million improvement in operating working capital cash flow, specifically the reduction in inventory levels.